NCT00144807 - ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma | Biotech Hunter

Enrollment

128

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

September 30, 2008

Study Completion Date

April 30, 2012

Conditions

Diffuse Large Cell Lymphoma

Interventions

DRUG

rituximab

DRUG

doxorubicin

DRUG

cyclophosphamide

PROCEDURE

autologous stem cell transplantation

Trial Locations (13)

31059

Hématologie CHU Purpan, Toulouse

33300

Polyclinique Bordeaux Nord, Bordeaux

51092

Centre Hospitalier Robert Debré, Reims

59000

Hématologie CHU de Lille, Lille

69008

Centre Léon Bérard, Lyon

69495

Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite

75010

Hôpital Saint Louis, Paris

75743

Hématologie Adultes - Hôpital Necker, Paris

76038

Centre Henri Becquerel, Rouen

94010

Hôpital Henri Mondor, Créteil

Unknown

Groupe d'Etude des Lymphomes de l'adulte, Mont-Godinne

Institut Gustave Roussy, Villejuif

Schweirische Arbeitsgruppe fur klinische Krebsforschung, Lausanne

All Listed Sponsors

lead

Lymphoma Study Association

OTHER